NCT00016159View on ClinicalTrials.gov

Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

March 31, 2007

Conditions
Leukemia
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

lintuzumab

DRUG

arsenic trioxide

DRUG

idarubicin

DRUG

tretinoin

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00016159 - Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia | Biotech Hunter | Biotech Hunter